THE SAFETY OF MEDICINES USED IN NAUSEA (VOMITING) AND ACID-DEPENDENT DISEASES DURING PREGNANCY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper presents data on the safety of medicines used during pregnancy to treat nausea (vomiting) and acid-dependent diseases.

Full Text

Restricted Access

About the authors

E. Ushkalova

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: eushk@yandex.ru
Professor MD

References

  1. Saha S., Manlolo J., McGowan C. et al. Gastroenterology consultations in pregnancy // J. Womens Health (Larchmt). 2011; 20 (3): 359-63.
  2. Bianco A., Lockwood С., Barss V. Maternal gastrointestinal tract adaptation to pregnancy. Uptodate, 2012 http://www.uptodate.com/contents/maternal-gastrointestinal-tract-adaptation-to-pregnancy
  3. Seto A., Einarson T., Koren G. Pregnancy outcome following first trimester exposure to antihistamines: Meta-analysis // Am. J. Perinatol. 1997; 14: 119-24.
  4. Magee L., Mazzotta P., Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP) // Am. J. Obstet. Gynecol. 2002; 186: 256-61.
  5. Mazzotta P., Magee L. A risk-benefit assessment of pharmacological and nonpharmacological treatment of nausea and vomiting of pregnancy // Drugs. -2000; 59 (4): 781-800.
  6. King T., Murphy P. Evidence-Based Approaches to Managing Nausea and Vomiting in Early Pregnancy // J. Midwifery Womens Health. 2009; 54 (6): 430
  7. Kallen B., Mottet I. Delivery outcome after the use of meclozine in early pregnancy // Eur. J. Epidemiol. 2003; 18 (7): 665-9.
  8. Asker C., Norstedt-Wikner B., Kallen B. Use of antiemetic drugs during pregnancy in Sweden // Eur. J. Clin. Pharmacol. 2005; 61 (12): 899-906.
  9. Arsenault M., Lane C., MacKinnon C. et al. The management of nausea and vomiting of pregnancy // J. Obstet. Gynaecol. Can. 2002; 24 (10): 817-31.
  10. McKeigue P., Lamm S., Linn S. et al. Bendectin and birth defects: I. A metaanalysis of the epidemiologic studies // Teratology. 1994; 50: 27.
  11. Matthews A., Dowswell T., Haas D. et al. Interventions for nausea and vomiting in early pregnancy // Cochrane Database Syst. Rev. 2010; 9: CD007575. 82013 ВРАЧ фармакология
  12. Arsenault M., Lane C., MacKinnon C. et al. The management of nausea and vomiting of pregnancy // J. Obstet. Gynaecol. Can. 2002; 24 (10): 817-31.
  13. FDA approves Diclegis for pregnant women experiencing nausea and vomiting http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm347087.htm
  14. Ding M., Leach M., Bradley H. The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: A systematic review // Women Birth. -2013; 26 (1): 26-30.
  15. Almeida J., Riordan S. The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy // Exp. Opin. Drug. Saf. -2007; 6 (5): 493-503.
  16. Sorensen H., Nielsen G., Christensen K. et al. Birth outcome following maternal use of metoclopramide. The Euromap study group // Br. J. Clin. Pharmacol. 2000; 49: 264-68.
  17. Berkovitch M., Mazzota P., Greenberg R. et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study // Am. J. Perinatol. 2002; 19: 311-6.
  18. Asker C., Norstedt-Wikner B., Kallen B. Use of antiemetic drugs during pregnancy in Sweden // Eur. J. Clin. Pharmacol. 2005; 61: 899-906.
  19. US department of education and welfare phs, national institutes of health: The Collaborative Study of the National Institute of Neurological Diseases: the women and their pregnancies. DHEW Publication No. (NIH) 73-379 (1972).
  20. Schwethel M., Margolis L., Miller C. et al. Risk status and pregnancy outcome among Medicaid recipients // Am. J. Prev. Med. 1989; 5: 157-63.
  21. Einarson-Maltepe C., Navioz Y. et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study // BJOG. 2004; 111: 940-3.
  22. Richter J. Review article: the management of heartburn in pregnancy // Aliment. Pharmacol. Ther. 2005; 22: 749-57.
  23. Mahadevan U., Kane S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy // Gastroenterology. 2006; 131 (1): 278-82.
  24. Mahadevan U. Gastrointestinal medications in pregnancy // Best Pract. Res. Clin. Gastroenterol. 2007; 21 (5): 849-77.
  25. McGuinness Bio, Logan J. Milk alkali syndrome // Ulster Med. J. 2002; 71 (2): 132-5.
  26. Gordon M., McMahon L., Hamblin P. Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy // Med. J. Aust. 2005; 182 (7): 350-1.
  27. Harris B., Choma D. et al. Hypercalcemia in Pregnancy: A Case of Milk-Alkali Syndrome // J. Gen. Intern. Med. 2011; 26 (8): 939-42.
  28. Robertson W. Calcium carbonate consumption during pregnancy: an unusual cause of neonatal hypocalcemia // J. Child. Neurol. 2002; 17: 853-5.
  29. Charan M., Katz P. Gastroesophageal reflux disease in pregnancy // Cur. Treat. Opt. Gastroenterol. 2001; 4: 73-81.
  30. Briggs G., Freeman R., Yaffe S. Drugs in Pregnancy and Lactation. Philadelphia, Lippincott Williams & Wilkins, 2008.
  31. Cappell M. Gastric and duodenal ulcers during pregnancy // Gastroenterol. Clin. North. Am. 2003; 32: 263-308.
  32. Gill S., O'Brien L., Koren G. The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis // Dig. Dis. Sci. 2009; 54 (9): 1835-8.
  33. Matok I., Gorodischer R., Koren G. et al. The safety of H(2)-blockers use during pregnancy // J. Clin. Pharmacol. 2010; 50 (1): 81-7.
  34. Cappell M., Friedel D. Abdominal pain during pregnancy // Gastroenterol. Clin. North Am. 2003; 32 (1): 1-58.
  35. Fill S., Malfertheiner M., Costa S. et al. Handling of the gastroesophageal reflux disease (GERD) during pregnancy a review // Z. Geburtshilfe Neonatol. -2007; 211 (6): 215-23.
  36. Gill S., O'Brien L., Einarson T. et al. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis // Am. J. Gastroenterol. 2009; 104 (6): 1541-5.
  37. Majithia R., Johnson D. Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date // Drugs. 2012; 72 (2): 171-9.
  38. Erichsen R., Mikkelsen E., Pedersen L. et al. Maternal Use of Proton Pump Inhibitors During Early Pregnancy and the Prevalence of Hypospadias in Male Offspring // Am. J. Ther., 2012; Epub. ahead of print.
  39. Dulgheru R. The Safety and Efficiency of Proton Pump Inhibitors during Pregnancy and Conception // Maedica (Buchar). 2010; 5 (4): 304.
  40. Matok I., Levy A., Wiznitzer A. et al. The safety of fetal exposure to proton-pump inhibitors during pregnancy // Dig. Dis. Sci. 2012; 57 (3): 699-705.
  41. Pasternak B., Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects // N. Engl. J. Med. 2010; 363: 2114.
  42. Andersen A., Erichsen R., Farkas D. et al. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study // Aliment Pharmacol. Ther. 2012; 35 (10): 1190-8.
  43. Jonville A., Lionnet C., Swar A. et al. Drug utilization at the end of pregnancy // Therapie. 1991; 46: 379-82.
  44. Kallen B. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole // Br. J. Obstet. Gynaecol. 1998; 105: 877-81.
  45. Ruigomez A., Garcia-Rodriguez L., Cattaruzzi C. et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes // Am. J. Epidemiol. 1999; 150: 476-81.
  46. Magee L., Inocencion G., Kamboj L. et al. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study // Dig. Dis. Sci. 1996; 41: 1145-9.
  47. Garbis H., Elefant E., Diav-Citrin O. et al. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services // Reprod. Toxicol. 2005; 19: 453-8.
  48. Ruigomez A., Garcia-Rodriguez L., Cattaruzzi C. et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes // Am. J. Epidemiol. 1999; 150: 476.
  49. Diav-Citrin O., Arnon J., Shechtman S. et al. The safety of proton pump inhibitors in pregnancy: a multi-centre prospective controlled study // Aliment. Pharmacol. Ther. 2005; 21: 269-75.
  50. Kallen B. Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy // Eur. J. Obstet. Gynecol. Reprod. Biol. -2001; 96 (1): 63-8.
  51. Lalkin A., Loebstein R., Addis A. et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study // Am. J. Obstet. Gynecol. -1998; 179: 727-30.
  52. Shaban M., Kandil H., Elshafei A. Helicobacter Pylori Seropositivity in Patients With Hyperemesis Gravidarum // Am. J. Med. Sci., 2013. Epub. ahead of print.
  53. Mansour G., Nashaat E. Role of Helicobacter pylori in the pathogenesis of hyperemesis gravidarum // Arch. Gynecol. Obstet. 2011; 284 (4): 843-7.
  54. Einarson A., Phillips E., Mawji F. et al. A prospective controlled multicentre study of clarithromycin in pregnancy // Am. J. Perinatol. 1998; 15 (9): 523-5.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies